MPM BioVentures 2018 reports Entrada Therapeutics common stock disposal worth $471,391.64
TRDA•MPM BioVentures 2018 sells Entrada Therapeutics shares
- MPM BioVentures 2018 sold 62,714 Entrada Therapeutics common shares in open-market trades on Aug. 24-26, 2026.
- Sales priced at USD 7.34, USD 7.54, USD 7.06; indirect stake fell to 4,318,348 shares.
